Sign In
Buy APYX
$4.10
-0.0200 (-0.485%)
At Close: Jul 31, 2026
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
07:30am, Thursday, 30'th Jun 2022
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold
Why Are Apyx Medical Shares Trading Higher Today?
12:25pm, Thursday, 26'th May 2022
Apyx Medical Corporation (NASDAQ: APYX) has FDA received 510(k) clearance for the use of the Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
02:02pm, Friday, 20'th May 2022 Benzinga
Upgrades
For Telia Company AB (OTC:TLSNY), UBS upgraded the previous rating of Neutral to Buy. For the first quarter, Telia Company had an EPS of $0.05, compared to year-ago quarter EPS of $0.03. The
Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q1 2022 Results - Earnings Call Transcript
02:21pm, Thursday, 12'th May 2022
Apyx Medical Corporation (NASDAQ:APYX ) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Charles Goodwin - President & Chief Executive Officer Tara Semb - Chief Financial
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
12:15pm, Thursday, 12'th May 2022 Zacks Investment Research
Apyx (APYX) delivered earnings and revenue surprises of -30.77% and 7.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
09:47am, Thursday, 12'th May 2022
Apyx (APYX) delivered earnings and revenue surprises of -30.77% and 7.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Quidel (QDEL) Q1 Earnings and Revenues Top Estimates
09:55pm, Wednesday, 04'th May 2022 Zacks Investment Research
Quidel (QDEL) delivered earnings and revenue surprises of 25.65% and 21.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Vascular (LMAT) Q1 Earnings Miss Estimates
09:55pm, Thursday, 28'th Apr 2022 Zacks Investment Research
LeMaitre (LMAT) delivered earnings and revenue surprises of -3.57% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
04:05pm, Monday, 04'th Apr 2022
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold
Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q4 2021 Results - Earnings Call Transcript
11:32am, Thursday, 17'th Mar 2022
Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q4 2021 Results - Earnings Call Transcript
Apyx Medical sinks on safety concern for product technology
04:31pm, Monday, 14'th Mar 2022 Seeking Alpha
Medical device maker Apyx Medical Corporation (APYX) is trading sharply lower on Monday after the company warned that the U.S
Molina (MOH) to Join S&P 500 Driven by Medicare Performance
05:01pm, Monday, 28'th Feb 2022 Zacks Investment Research
Molina Healthcare (MOH) is likely to leave S&P MidCap 400 and replace IHS Markit Ltd. in the S&P 500 Index.
Apyx Medical Submits Additional FDA 510(k) For Expanded Use Of Renuvion In Dermatological Procedures
05:26pm, Thursday, 17'th Feb 2022 Benzinga
Apyx Medical Corporation (NASDAQ: APYX ) announced the publication of an article in a journal featuring the results of its U.S. IDE study evaluating the Renuvion Dermal Handpiece using Apyx''s Helium Plasma Technology for dermal resurfacing procedures. The Company has also submitted a 510(k) premarket notification to the FDA. The primary efficacy endpoint was achieved, with 100% of the study''s subjects achieving a more than … Full story available on Benzinga.com
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022
07:30am, Thursday, 27'th Jan 2022
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold
Medtronic (MDT) Undertakes Investment to Advance STEM Education
02:52pm, Monday, 24'th Jan 2022 Zacks Investment Research
The Medtronic Foundation, solely funded by Medtronic plc (MDT), entered into 13 new partnerships to bridge the inequity in STEM education among underrepresented and underserved communities.
